Glaukos Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Glaukos Corp 公司

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Glaukos Corp简介



公司代码GKOS

公司名称Glaukos Corp

上市日期Jun 25, 2015

CEOBurns (Thomas William)

员工数量995

证券类型Ordinary Share

年结日Jun 25

公司地址1 Glaukos Way

城市ALISO VIEJO

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编92656

电话19493679600

网址https://www.glaukos.com

公司代码GKOS

上市日期Jun 25, 2015

CEOBurns (Thomas William)

Glaukos Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

--

Mr. David F. Hoffmeister

Independent Director

70.27K

+753.00%

Mr. Mark J. Foley

Lead Independent Director

57.52K

+1168.00%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.85K

+623.00%

Mr. Marc A. Stapley

Independent Director

36.91K

+727.00%

Dr. Tomas Navratil

Chief Development Officer

34.86K

+1544.00%

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

--

Mr. Joseph E. Gilliam

President, Chief Operating Officer

--

Dr. Leana S. Wen, M.D.

Independent Director

--

Ms. Denice M. Torres, J.D.

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

--

Mr. David F. Hoffmeister

Independent Director

70.27K

+753.00%

Mr. Mark J. Foley

Lead Independent Director

57.52K

+1168.00%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.85K

+623.00%

Mr. Marc A. Stapley

Independent Director

36.91K

+727.00%

Dr. Tomas Navratil

Chief Development Officer

34.86K

+1544.00%

收入明细

单位: USD更新时间: 1月6日周二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Glaucoma

110.25M

82.56%

Corneal Health

23.29M

17.44%

地区USD

名称

营收

占比

United States

101.45M

75.97%

International

32.09M

24.03%

业务

地区

业务USD

名称

营收

占比

Glaucoma

110.25M

82.56%

Corneal Health

23.29M

17.44%

股东统计

更新时间: 1月31日周六

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.46%

Wellington Management Company, LLP

6.23%

PRIMECAP Management Company

3.92%

State Street Investment Management (US)

3.66%

其他

62.13%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.46%

Wellington Management Company, LLP

6.23%

PRIMECAP Management Company

3.92%

State Street Investment Management (US)

3.66%

其他

62.13%

股东类型

持股股东

占比

Investment Advisor

48.90%

Investment Advisor/Hedge Fund

35.43%

Hedge Fund

10.15%

Individual Investor

3.31%

Research Firm

2.10%

Pension Fund

2.05%

Sovereign Wealth Fund

1.32%

Bank and Trust

0.92%

Venture Capital

0.64%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

679

58.33M

101.56%

-6.75M

2025Q3

653

61.34M

106.80%

+235.97K

2025Q2

638

61.06M

106.48%

+15.37K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.81M

13.59%

-89.56K

-1.13%

Sep 30, 2025

The Vanguard Group, Inc.

6.03M

10.5%

-65.70K

-1.08%

Sep 30, 2025

Wellington Management Company, LLP

3.58M

6.23%

+336.27K

+10.36%

Sep 30, 2025

PRIMECAP Management Company

2.25M

3.92%

+425.79K

+23.29%

Sep 30, 2025

State Street Investment Management (US)

2.10M

3.66%

+14.00K

+0.67%

Sep 30, 2025

AllianceBernstein L.P.

1.73M

3.02%

+481.62K

+38.47%

Sep 30, 2025

Burns (Thomas William)

1.51M

2.63%

+3.07K

+0.20%

Dec 30, 2025

Geode Capital Management, L.L.C.

1.32M

2.29%

-14.51K

-1.09%

Sep 30, 2025

Columbia Threadneedle Investments (US)

1.27M

2.21%

+247.45K

+24.25%

Sep 30, 2025

Westfield Capital Management Company, L.P.

1.23M

2.14%

+63.79K

+5.46%

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

Invesco S&P SmallCap Health Care ETF

3.09%

Alger Weatherbie Enduring Growth ETF

2.07%

State Street SPDR S&P Health Care Equipment ETF

1.79%

ROBO Global Healthcare Technology & Innovation ETF

1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.65%

iShares S&P Small-Cap 600 Growth ETF

0.64%

iShares U.S. Medical Devices ETF

0.6%

OneAscent Enhanced Small and Mid Cap ETF

0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

0.51%

Invesco S&P SmallCap Health Care ETF

占比3.09%

Alger Weatherbie Enduring Growth ETF

占比2.07%

State Street SPDR S&P Health Care Equipment ETF

占比1.79%

ROBO Global Healthcare Technology & Innovation ETF

占比1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

占比0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

占比0.65%

iShares S&P Small-Cap 600 Growth ETF

占比0.64%

iShares U.S. Medical Devices ETF

占比0.6%

OneAscent Enhanced Small and Mid Cap ETF

占比0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

占比0.51%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据